3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year Post author:Sam Post published:November 20, 2017 Post category:BioPharma Investors have had a decent year, but some have much to be grateful for this Thanksgiving. Source: BioSpace You Might Also Like Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017 Sarepta???s Exondys 51 Saga Continues as More Details About FDA???s Criticism Uncovered August 21, 2017 The Alliance for Regenerative Medicine (ARM) Releases Q2 2017 Data Report, Highlighting Sector Trends And Metrics August 17, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
Sarepta???s Exondys 51 Saga Continues as More Details About FDA???s Criticism Uncovered August 21, 2017
The Alliance for Regenerative Medicine (ARM) Releases Q2 2017 Data Report, Highlighting Sector Trends And Metrics August 17, 2017